The tumor microenvironment is a dominant force in multidrug resistance.

Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy
Ana Luísa Correia, Mina J Bissell

Abstract

The emergence of clinical drug resistance is still one of the most challenging factors in cancer treatment effectiveness. Until more recently, the assumption has been that random genetic lesions are sufficient to explain the progression of malignancy and escape from chemotherapy. Here we propose an additional perspective, one in which the tumor cells despite the malignant genome could find a microenvironment either within the tumor or as a dormant cell to remain polar and blend into an organized context. Targeting this dynamic interplay could be considered a new avenue to prevent therapeutic resistance, and may even provide a promising effective cancer treatment.

References

Aug 1, 1979·International Journal of Radiation Oncology, Biology, Physics·R M SutherlandD Vanantwerp
Oct 1, 1992·Proceedings of the National Academy of Sciences of the United States of America·O W PetersenM J Bissell
Oct 1, 1991·Current Opinion in Cell Biology·D Ingber
Sep 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R FridmanJ L Mulshine
Jan 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·J L CampsL W Chung
Apr 19, 1989·Journal of the National Cancer Institute·R K Jain
Oct 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·A R HowlettM J Bissell
Nov 8, 1985·Science·D S DolbergM J Bissell
Mar 1, 1972·Experimental Cell Research·R E Durand, R M Sutherland
Nov 7, 1982·Journal of Theoretical Biology·M J BissellG Parry
Sep 1, 1993·Journal of the National Cancer Institute·K PantelG Riethmüller
Feb 1, 1994·The Journal of Cell Biology·S M Frisch, H Francis
Apr 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·H KobayashiR S Kerbel
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·A J ManiotisD E Ingber
Jan 1, 1997·Annual Review of Physiology·D E Ingber
Sep 18, 1997·Journal of the National Cancer Institute·A F Chambers, L M Matrisian
Mar 14, 1998·Proceedings of the National Academy of Sciences of the United States of America·M Skobe, N E Fusenig
Jan 16, 1999·Journal of the National Cancer Institute·T G KarrisonP Meier
Mar 31, 1999·Trends in Biochemical Sciences·C V Dang, G L Semenza
Apr 10, 1999·Ultrasonic Imaging·T A KrouskopT Hall
Jul 30, 1999·Journal of Mammary Gland Biology and Neoplasia·V M Weaver, M J Bissell
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·T EbiharaM S Ludwig
Mar 22, 2001·Advanced Drug Delivery Reviews·R K Jain
Apr 27, 2001·Seminars in Cancer Biology·D RadiskyM J Bissell
Apr 27, 2001·Seminars in Cancer Biology·W G Stetler-Stevenson, A E Yu

❮ Previous
Next ❯

Citations

Sep 26, 2012·Annals of Biomedical Engineering·Anirikh ChakrabartiJeffrey D Varner
Feb 26, 2014·Biochemical Pharmacology·Claudio PisanoFranco Zunino
Mar 29, 2013·Nature Reviews. Cancer·Michael HölzelThomas Tüting
Dec 7, 2013·PloS One·Annaïck DesmaisonValérie Lobjois
Aug 27, 2013·Endocrine-related Cancer·W Nathaniel BrennenJohn T Isaacs
Sep 6, 2012·International Journal of Molecular Sciences·Magali CastellsBettina Couderc
Oct 31, 2013·Trends in Molecular Medicine·Anna JohanssonRuth Ganss
May 8, 2014·BioMed Research International·Radosław JanuchowskiMaciej Zabel
May 9, 2014·Bioinformatics·Rotem Ben-HamoSol Efroni
Aug 15, 2014·Biotechnology Advances·Xian XuXinqiao Jia
Jul 11, 2013·Leukemia & Lymphoma·Viralkumar PatelVarsha Gandhi
Jun 1, 2014·Cancers·Anja van de Stolpe, Jaap M J den Toonder
May 7, 2016·Current Opinion in Chemical Engineering·Zen Liu, Gordana Vunjak-Novakovic
Mar 5, 2016·Oncoimmunology·Stefanie Andrea Erika HeldPeter Brossart
Aug 10, 2015·Biochimica Et Biophysica Acta·Emyr BakkerMarija Krstic-Demonacos
Dec 15, 2015·Trends in Pharmacological Sciences·Ramaswamy KrishnanAlastair Stewart
Oct 17, 2012·Trends in Cell Biology·Jennifer S Liu, Zev J Gartner
Mar 5, 2016·Current Opinion in Biotechnology·Fabian SpillMuhammad H Zaman
Sep 17, 2015·Acta Biochimica Et Biophysica Sinica·Beiqin Yu, Jingwu Xie
Dec 17, 2015·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Jeong Hyun ChoJong Kuk Park
Sep 30, 2015·Seminars in Cancer Biology·Marta GiussaniMaria Grazia Daidone
Aug 19, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Lei MiaoLeaf Huang
Feb 12, 2013·Evolutionary Applications·C Athena Aktipis, Randolph M Nesse
Jan 21, 2014·International Journal of Cancer. Journal International Du Cancer·Hua ZhongGalina V Shurin
Jan 27, 2015·Bioengineered·Aranzazu Villasante, Gordana Vunjak-Novakovic
Aug 14, 2015·Langmuir : the ACS Journal of Surfaces and Colloids·Amita DavereySrivatsan Kidambi
Apr 12, 2016·Scientific Reports·Martina BaarAnton Bovier
Aug 24, 2013·Molecular and Cellular Endocrinology·Camilla Ingeson-Carlsson, Mikael Nilsson
Jun 10, 2014·Seminars in Cancer Biology·Jürgen Dittmer, Benjamin Leyh
Jul 17, 2015·Cancer Cell International·Khalid O AlfaroukCyril Rauch
Jun 20, 2015·Genome Biology·Eun-Yeong OhAndrew H Beck
Mar 10, 2015·Journal of Biotechnology·Oliver Ingo HoffmannBarbara Mayer
Apr 11, 2015·Cancer Cell·Brian Ruffell, Lisa M Coussens
Mar 10, 2016·Journal of Nanobiotechnology·Sten Friberg, Andreas M Nyström

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Related Papers

Journal of the National Cancer Institute
Olivier TrédanIan F Tannock
© 2022 Meta ULC. All rights reserved